Sunday newspaper round-up: Delta mutation, Foreign summer holidays, Anglo American
6th Jun 2021 12:20
(Sharecast News) - The decision to reopen on June 21 has been made "more difficult" by the Indian variant's spread to the most dominant variant in the UK, the Health Secretary has said. Matt Hancock told Sky News that the latest advice the Government has received is that the so-called Delta mutation first identified in India is 40 per cent more transmissible than the previously dominant Kent variant. - Sunday Telegraph
Read moreAstraZeneca names Dr Aradhana Sarin as CFO
4th Jun 2021 08:33
(Sharecast News) - Pharmaceutical group AstraZeneca has appointed Aradhana Sarin as chief financial officer on Friday, succeeding Marc Dunoyer upon the closing of its acquisition of Alexion Pharmaceuticals on 1 August.
Read moreEurope close: Stocks brush-off inflation readings helped by reports on US stimulus
28th May 2021 18:48
(Sharecast News) - European shares pushed further into record territory on Friday with investors apparently brushing off data in the US showing quickening inflation.
Read moreAstraZeneca lung cancer drug receives EU approval
28th May 2021 07:45
(Sharecast News) - AstraZeneca said its Tagrisso cancer drug had been approved in the European Union after positive results from a phase 3 trial.
Read moreTuesday broker round-up
25th May 2021 13:07
(Sharecast News) - Travis Perkins: Deutsche Bank resumes coverage with a recommendation to hold and a target price of 1,707p.
Read moreSilence Therapeutics receives remaining $40m from AstraZeneca partnership
25th May 2021 12:35
(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.
Read moreUK's CMA to probe $39bn AstraZeneca-Alexion deal
25th May 2021 08:24
(Sharecast News) - Britain's Competition and Markets Authority (CMA) said it is looking into AstraZeneca's $39bn acquisition of America's Alexion Pharmaceuticals over concerns the deal could harm competition in the UK.
Read moreAstraZeneca Covid-19 vaccine approved for emergency use in Japan
21st May 2021 07:05
(Sharecast News) - AstraZeneca's Covid-19 vaccine has been granted a special approval for emergency use in Japan for people aged 18 years and older, the company said on Friday.
Read moreTuesday broker round-up
18th May 2021 14:00
(Sharecast News) - BP: Barclays upgrades to top pick with a target price of 475p.
Read moreOxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output
18th May 2021 08:13
(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Read moreMonday broker round-up
17th May 2021 14:38
(Sharecast News) - Diploma: Numis upgrades to add with a target price of 3,250p.
Read moreUK eases lockdown restrictions despite Indian variant threat
17th May 2021 10:16
(Sharecast News) - The UK relaxed social and economic restrictions on Monday despite the looming threat of the Indian Covid-19 variant.
Read moreFriday broker round-up
14th May 2021 12:57
(Sharecast News) - NCC Group: Canaccord upgrades to buy with a target price of 318p.
Read moreUK prepares to 'flex' vaccination program to tackle Indian Covid-19 variant
14th May 2021 11:16
(Sharecast News) - UK vaccines minister Nadhim Zahawi said on Friday that the government was gearing up to "flex" its inoculation program in order to tackle the new coronavirus variant first detected in India.
Read moreWednesday broker round-up
12th May 2021 13:55
(Sharecast News) - Air Partner: Canaccord reiterates buy with a target price of 100p.
Read more